The bioanalytical testing services market presents key opportunities in specialized testing for complex therapeutics, driven ...

Given the multifaceted nature of ADCs, developers should have an integrated analytical toolkit. Three complementary approaches dominate the current landscape: Ligand Binding Assays (LBA): Ideal for ...

Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.

Agricultural production is declining at an increasing rate due to the effects of climate change, including water, salt, and ...

Scinai Immunotherapeutics Ltd. ; ("Scinai", or the "Company"), a biopharmaceutical company developing inflammation and immunology (I&I) therapeutics and operating a growing boutique CDMO business unit ...

The sheer growth of small biotechs and mid‑sized pharma companies entering the field has reshaped expectations of Contract Development and Manufacturing Organisations (CDMOs).

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of an advanced animal mRNA vaccine platform to accelerate the development ...

YD BioMed expects to advance two lead ophthalmology programs utilizing its LSC Exosome platform, each supported by targeted regulatory and clinical milestones, which the timing of these milestones ...

The FDA has proposed new policies to speed up the development and lower the cost of biosimilar agents for cancer and other serious illnesses. These policies include “major updates to simplify ...

Instead of requiring personalized gene edits for each patient, the new approach could create a standardized method to use for many diseases. By Pam Belluck and Carl Zimmer Gene-editing therapies offer ...

SAN FRANCISCO, Nov 13 - ChatGPT maker OpenAI on Thursday said it will invest in a startup focused on blocking bad actors from creating biological weapons powered by artificial intelligence. OpenAI is ...